相似文献
1
A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD.
J Atten Disord. 2014 Feb;18(2):158-68. doi: 10.1177/1087054712440320. Epub 2012 Apr 16.
2
Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.
BMC Pharmacol Toxicol. 2012 Dec 19;13:18. doi: 10.1186/2050-6511-13-18.
3
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.
Clin Ther. 2007 Mar;29(3):450-63. doi: 10.1016/s0149-2918(07)80083-x.
4
Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study.
BMC Psychiatry. 2013 Oct 9;13:253. doi: 10.1186/1471-244X-13-253.
5
Randomized, double-blind, placebo-controlled, crossover study of the effects of lisdexamfetamine dimesylate and mixed amphetamine salts on cognition throughout the day in adults with attention-deficit/hyperactivity disorder.
Clin Drug Investig. 2014 Feb;34(2):147-57. doi: 10.1007/s40261-013-0156-z.
6
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry. 2011 Apr;50(4):395-405. doi: 10.1016/j.jaac.2011.01.007. Epub 2011 Mar 3.
7
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
BMC Psychiatry. 2013 Jan 29;13:39. doi: 10.1186/1471-244X-13-39.
8
Does pharmacological treatment of ADHD in adults enhance parenting performance? Results of a double-blind randomized trial.
CNS Drugs. 2014 Jul;28(7):665-77. doi: 10.1007/s40263-014-0165-3.
9
Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design.
Behav Brain Funct. 2010 Jun 24;6:34. doi: 10.1186/1744-9081-6-34.
10
Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study.
J Atten Disord. 2012 Feb;16(2):118-27. doi: 10.1177/1087054711403716. Epub 2011 Apr 28.
引用本文的文献
1
The co-use of nicotine and prescription psychostimulants: A review of their behavioral and neuropharmacological interactions.
Drug Alcohol Depend. 2023 Jul 1;248:109906. doi: 10.1016/j.drugalcdep.2023.109906. Epub 2023 May 4.
2
TOBACCO USE DISORDER AND DUAL DISORDERS Joint statement by the Spanish Psychiatry Society and the Spanish Dual Disorders Society.
Actas Esp Psiquiatr. 2022 Jun;50(Supplement):77-138. Epub 2022 Jun 1.
3
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
PLoS One. 2020 Oct 21;15(10):e0240584. doi: 10.1371/journal.pone.0240584. eCollection 2020.
4
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD007813. doi: 10.1002/14651858.CD007813.pub3.
5
Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study.
J Child Psychol Psychiatry. 2018 Jun;59(6):692-702. doi: 10.1111/jcpp.12855. Epub 2018 Jan 8.
6
ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.
Neuropsychopharmacology. 2018 Mar;43(4):851-858. doi: 10.1038/npp.2017.248. Epub 2017 Oct 20.
7
Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?
Harv Rev Psychiatry. 2017 Mar/Apr;25(2):50-64. doi: 10.1097/HRP.0000000000000122.
8
Ecological momentary assessment of antecedents and consequences of smoking in adults with attention-deficit/hyperactivity disorder.
Subst Use Misuse. 2014 Sep;49(11):1446-56. doi: 10.3109/10826084.2014.912229. Epub 2014 May 14.
9
Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.
Pediatrics. 2014 Jun;133(6):1070-80. doi: 10.1542/peds.2014-0179. Epub 2014 May 12.
10
ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:70-8. doi: 10.1016/j.pnpbp.2014.02.002. Epub 2014 Feb 18.
本文引用的文献
1
Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.
Curr Med Res Opin. 2011;27 Suppl 2:23-33. doi: 10.1185/03007995.2011.605441.
2
An examination of the effects of stimulant medication on response inhibition: a comparison between children with and without attention deficit hyperactivity disorder.
Res Dev Disabil. 2011 Nov-Dec;32(6):2797-804. doi: 10.1016/j.ridd.2011.05.027. Epub 2011 Jun 22.
3
Methylphenidate increases cigarette smoking in participants with ADHD.
Psychopharmacology (Berl). 2011 Nov;218(2):381-90. doi: 10.1007/s00213-011-2328-y. Epub 2011 May 18.
4
Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial.
Nicotine Tob Res. 2011 Sep;13(9):784-92. doi: 10.1093/ntr/ntr073. Epub 2011 May 12.
5
Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability.
Biol Psychiatry. 2011 May 1;69(9):902-4. doi: 10.1016/j.biopsych.2010.11.014. Epub 2010 Dec 30.
6
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.
J Child Adolesc Psychopharmacol. 2010 Dec;20(6):503-11. doi: 10.1089/cap.2009.0110.
7
An updated meta-analysis of nicotine preloading for smoking cessation: investigating mediators of the effect.
Psychopharmacology (Berl). 2011 Apr;214(3):579-92. doi: 10.1007/s00213-010-2069-3.
8
Methylphenidate increases choice of cigarettes over money.
Nicotine Tob Res. 2011 Jan;13(1):29-33. doi: 10.1093/ntr/ntq198. Epub 2010 Nov 8.
9
Why does ADHD confer risk for cigarette smoking? A review of psychosocial mechanisms.
Clin Child Fam Psychol Rev. 2010 Sep;13(3):291-313. doi: 10.1007/s10567-010-0070-3.
10
Pre-cessation nicotine replacement therapy: pragmatic randomized trial.
Addiction. 2010 Aug;105(8):1474-83. doi: 10.1111/j.1360-0443.2010.02989.x. Epub 2010 Jun 7.
Zotero 插件